[1] |
Allouch S, Malki A, Allouch A, et al. High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions[J]. Front Oncol, 2020, 10:914. doi: 10.3389/fonc.2020.00914.
doi: 10.3389/fonc.2020.00914
pmid: 32695664
|
[2] |
魏丽惠. 面向加速消除宫颈癌的挑战[J]. 中国妇产科临床杂志, 2021, 22(1):1-2. doi: 10.13390/j.issn.1672-1861.2021.01.001.
doi: 10.13390/j.issn.1672-1861.2021.01.001
|
[3] |
Duan R, Xu K, Huang L, et al. Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007-2030[J]. Cancer Epidemiol Biomarkers Prev, 2022, 31(5):1130-1136. doi: 10.1158/1055-9965.EPI-21-1124.
doi: 10.1158/1055-9965.EPI-21-1124
|
[4] |
Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis[J]. Lancet Glob Health, 2020, 8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6.
doi: 10.1016/S2214-109X(19)30482-6
|
[5] |
Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors[J]. J Low Genit Tract Dis, 2020, 24(2):102-131. doi: 10.1097/LGT.0000000000000525.
doi: 10.1097/LGT.0000000000000525
|
[6] |
Safaeian M, Wright TC Jr, Stoler MH, et al. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase[J]. Am J Obstet Gynecol, 2021, 225(3):278.e1-278.e16. doi: 10.1016/j.ajog.2021.03.047.
doi: 10.1016/j.ajog.2021.03.047
|
[7] |
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention[EB/OL]. 2nd ed. Geneva: World Health Organization, 2021.
|
[8] |
薛鹏, 王福媛, 李晴, 等. 阴道镜对宫颈病变诊断价值的荟萃分析[J]. 国际妇产科学杂志, 2021, 48(2):159-164. doi: 10.12280/gjfckx.20200748.
doi: 10.12280/gjfckx.20200748
|
[9] |
Kim SI, Kim SJ, Suh DH, et al. Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions[J]. J Gynecol Oncol, 2020, 31(2):e13. doi: 10.3802/jgo.2020.31.e13.
doi: 10.3802/jgo.2020.31.e13
|
[10] |
Ren H, Jia M, Zhao S, et al. Factors Correlated with the Accuracy of Colposcopy-Directed Biopsy: A Systematic Review and Meta-Analysis[J]. J Invest Surg, 2022, 35(2):284-292. doi: 10.1080/08941939.2020.1850944.
doi: 10.1080/08941939.2020.1850944
|
[11] |
Stuebs FA, Schulmeyer CE, Mehlhorn G, et al. Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study[J]. Arch Gynecol Obstet, 2019, 299(2):525-532. doi: 10.1007/s00404-018-4953-8.
doi: 10.1007/s00404-018-4953-8
pmid: 30367250
|
[12] |
Lang L, Jia Y, Duan Z, et al. The role of endocervical curettage in detection and treatment of cervical canal lesions[J]. Histol Histopathol, 2022, 37(1):63-68. doi: 10.14670/HH-18-394.
doi: 10.14670/HH-18-394
|
[13] |
谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018:297.
|
[14] |
Fontham E, Wolf A, Church TR, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2020, 70(5):321-346. doi: 10.3322/caac.21628.
doi: 10.3322/caac.21628
|
[15] |
周晖, 刘昀昀, 罗铭, 等. 2022 NCCN子宫颈癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2021, 37(12):1220-1226.
|
[16] |
Jenkins TM, Shojaei H, Song SJ, et al. Role of Ancillary Techniques in Cervical Biopsy and Endocervical Curettage Specimens as Follow-Up to Papanicolaou Test Results Indicating a Diagnosis of Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion, or High-Grade Squamous Intraepithelial Lesion[J]. Acta Cytol, 2020, 64(1/2):155-165. doi: 10.1159/000498888.
doi: 10.1159/000498888
|
[17] |
Andersson S, Megyessi D, Belkić K, et al. Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment[J]. Oncol Lett, 2021, 22(3):684. doi: 10.3892/ol.2021.12945.
doi: 10.3892/ol.2021.12945
pmid: 34434283
|
[18] |
Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors[J]. Cochrane Database Syst Rev, 2018, 5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
doi: 10.1002/14651858.CD009069.pub3
|
[19] |
Alder S, Megyessi D, Sundström K, et al. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study[J]. Am J Obstet Gynecol, 2020, 222(2):172.e1-e12. doi: 10.1016/j.ajog.2019.08.042.
doi: 10.1016/j.ajog.2019.08.042
|
[20] |
Fernández-Montolí ME, Tous S, Medina G, et al. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study[J]. BJOG, 2020, 127(3):377-387. doi: 10.1111/1471-0528.15996.
doi: 10.1111/1471-0528.15996
|
[21] |
Tidy JA, Lyon R, Ellis K, et al. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study[J]. BJOG, 2020, 127(10):1260-1267. doi: 10.1111/1471-0528.16250.
doi: 10.1111/1471-0528.16250
|
[22] |
Zhao Y, Zhao F, Hu S, et al. Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies[J]. Chin J Cancer Res, 2020, 32(3):383-394. doi: 10.21147/j.issn.1000-9604.2020.03.09.
doi: 10.21147/j.issn.1000-9604.2020.03.09
|
[23] |
Jones R, Dale F, Fite JJ, et al. Endocervical glandular involvement is associated with an increased detection rate of high-grade squamous intraepithelial lesions on the Papanicolaou test[J]. J Am Soc Cytopathol, 2020, 9(3):137-145. doi: 10.1016/j.jasc.2019.12.004.
doi: S2213-2945(20)30021-1
pmid: 32147423
|
[24] |
Spinillo A, Dominoni M, Boschi AC, et al. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia[J]. Gynecol Oncol, 2020, 159(3):630-635. doi: 10.1016/j.ygyno.2020.09.034.
doi: 10.1016/j.ygyno.2020.09.034
pmid: 33041069
|
[25] |
Ikeda M, Mikami M, Yasaka M, et al. Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology[J]. J Gynecol Oncol, 2021, 32(5):e68. doi: 10.3802/jgo.2021.32.e68.
doi: 10.3802/jgo.2021.32.e68
pmid: 34132067
|
[26] |
刘媛媛, 郭瑞霞, 李碧军, 等. 绝经后妇女子宫颈癌前病变的特点分析[J]. 中华妇产科杂志, 2021, 56(2):114-120. doi: 10.3760/cma.j.cn112141-20201010-00768.
doi: 10.3760/cma.j.cn112141-20201010-00768
|
[27] |
Abdulaziz A, You X, Liu L, et al. Management of high-grade squamous intraepithelial lesion patients with positive margin after LEEP conization: A retrospective study[J]. Medicine(Baltimore), 2021, 100(20):e26030. doi: 10.1097/MD.0000000000026030.
doi: 10.1097/MD.0000000000026030
|
[28] |
Fu K, Lei M, Yang WQ, et al. The treatment strategy of patients with positive margins after cervical cold knife conization-A 7-year retrospective study in China[J]. Int J Gynaecol Obstet, 2022, 156(1):159-165. doi: 10.1002/ijgo.13683.
doi: 10.1002/ijgo.13683
|
[29] |
Wang X, Xu J, Gao Y, et al. Necessity for subsequent surgery in women of child-bearing age with positive margins after conization[J]. BMC Womens Health, 2021, 21(1):191. doi: 10.1186/s12905-021-01329-x.
doi: 10.1186/s12905-021-01329-x
pmid: 33962590
|
[30] |
Li X, Liu M, Ji Y, et al. The effectiveness of cold-knife conization (CKC) for post-menopausal women with cervical high-grade squamous intraepithelial lesion: a retrospective study[J]. BMC Surg, 2021, 21(1):241. doi: 10.1186/s12893-021-01238-8.
doi: 10.1186/s12893-021-01238-8
pmid: 33975589
|